ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2015 American Transplant Congress

    Non-Invasive Diagnosis of Post Kidney Transplant Complications by Urinary Exosomal mRNA Analysis

    H. Harada,1 T. Murakami,2 C. Yamamoto,2 M. Mitsuhashi.2

    1Kidney Transplant Surgery, Sapporo City General Hospital, Sapporo, Japan; 2Hitachi Chemical Research Center, Inc., Irvine, CA.

    IntroductionMonitoring of kidney allograft status is important for the graft longevity. Conventional urinary markers are not sensitive and specific enough to diagnose graft injuries so…
  • 2015 American Transplant Congress

    Favorable Results of ABO Incompatible Renal Transplantation Without B Cell Targeted Therapy: Advantages and Disadvantages of Rituximab Pretreatment

    M. Okada,1 K. Futamura,1 K. Itou,1 T. Yamamoto,1 T. Hiramitsu,1 M. Tsujita,1 N. Goto,1 S. Narumi,1 Y. Watarai,1 A. Katayama,2 K. Uchida,3 T. Kobayashi.4

    1Nagoya Daini Red Cross Hospital, Nagoya, Japan; 2Masuko Memorial Hospital, Nagoya, Japan; 3Aichi Medical University, Nagakute, Japan; 4Nagoya University School of Medicine, Nagoya, Japan.

    INTRODUCTIONThe outcome of ABO-incompatible transplantation (ABO-I) has been reported to be comparable to that of ABO-identical/compatible transplantation (ABO-Id/C), which is considered to be due to…
  • 2015 American Transplant Congress

    Does Ureteric Stent Avoid Urological Complications After Renal Transplantation? A Retrospective Study of 10 Years Experience

    R. Kato, W. Nahas, K. Yamaçake, H. Kanashiro, R. Falci, A. Bull, I. Antonopoulos, G. Messi, A. Piovesan.

    Divison of Urology, Renal Transplantation Unit, University of São Paulo, São Paulo, SP, Brazil.

    PURPOSE: Urinary leakage and ureteral stenosis are the most common surgical complications after kidney transplantation and are associated with significant morbidity, mortality and prolonged hospital…
  • 2015 American Transplant Congress

    Long Term Follow Up Reveals Satisfactory Renal Outcome in Pacreas After Kidney Transplantation (PAK)

    R. Banga, V. Dadlani, W. Kremers, E. Lorenz, P. Dean, M. Stegall, Y. Kudva.

    Mayo Clinic, Rochester.

    Objective: PAK offers diabetic ESRD patients' opportunity to avoid or minimize dialysis using living kidney donation, followed by cadaveric pancreas transplantation thereafter to restore euglycemia,…
  • 2015 American Transplant Congress

    Regulatory Tolerance Across a Full MHC Barrier Is More Robust Than Tolerance Across a Class I MHC Disparity Alone

    M. Madariaga, S. Michel, G. La Muraglia II, M. O'Neil, W. Orent, V. Villani, M. Sekijima, E. Farkash, R. Colvin, J. Allan, K. Yamada, J. Madsen, D. Sachs.

    Transplantation Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA.

    Background: We previously demonstrated that tolerance of hearts and/or kidneys achieved across a class I MHC mismatch with 12 days of CyA can be abrogated…
  • 2015 American Transplant Congress

    Referral for Kidney Transplantation in Georgia: Data from the RaDIANT Community Study

    S. Pastan,1 J. Gander,1 L. Plantinga,1 L. Sauls,2 E. Gibney,3 L. Mulloy,4 J. Krisher,2 R. Patzer.1

    1Emory University, Atlanta; 2Southeastern Kidney Council, Raleigh; 3Piedmont Hospital, Atlanta; 4Georgia Regents University, Augusta, GA.

    PurposeThe rate of kidney transplantation (KTx) varies significantly across US dialysis facilities. Referral for KTx from dialysis facility providers is the first key step in…
  • 2015 American Transplant Congress

    Selective CD28 Blockade With or Without CD40-CD154 Blockade Promotes Cardiac Allograft Protection in Non-Human Primates

    T. Zhang,1 A. Kronfli,1 B. Gheorghe,1 L. Burdorf,1 E. Rybak,1 D. Parsell,1 D. Harris,1 E. Sievert,1 S. Dahi,1 N. Kubicki,1 J. Whoddal,1 M. Uluer,1 X. Cheng,1 E. Schwartz,1 K. Quinn,1 B. Vanhove,2 A. Azimzadeh,1 R. Pierson III.1

    1Surgery, University of Maryland School of Medicine, Baltimore, MD; 2INSERM, U643, Nants, France.

    Aim: Selective targeting CD28:B7 costimulation without interfering with CTLA-4-dependent immune regulation is theoretically an attractive approach to modulate pathogenic T cell-dependent immunity. We previously reported…
  • 2015 American Transplant Congress

    Everolimus Versus Mycophenolate for Recipients of Kidney Transplants from Expanded Criteria Donors (ECD) Receiving Anti-Thymocyte Globulin and Tacrolimus

    H. Tedesco-Silva,1 C. Felipe,1 A. Ferreira,1 M. Cristelli,1 A. Bessa,1 P. Ueno,1 T. Sandes- Freitas,1 G. Bassos,1 W. Aguiar,2 H. Proença,3 J. Medina-Pestana.1

    1Nephrology, Hospital do Rim UNIFESP, Sao Paulo, Brazil; 2Urology, Hospital do Rim UNIFESP, Sao Paulo, Brazil; 3Pathology, UNIFESP, Sao Paulo, Brazil.

    Introduction: Recipients of kidneys recovered from expanded criteria donors are at higher risk to develop delayed graft function (DGF) and acute rejection (AR), leading to…
  • 2015 American Transplant Congress

    Belatacept Based Immunosuppression and Incidence of Proteinuria in Kidney Transplant Recipients

    R. Villicana, A. Peng, J. Kahwaji, J. Choi, A. Vo, S. Jordan.

    Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA.

    Introduction: Abatacept which is a co-stimulation inhibitor has been suggested to have B7-1 mediated antiproteinuric effects. Belatacept which is another co-stimulation agent has been approved…
  • 2015 American Transplant Congress

    IL-21 Regulates Creation of Tertiary Lymphoid Organs in Chronic Allograft Rejection

    C. Baum,1 M. Khattar,2 P. Schroder,1 W. Chen,3 S. Stepkowski.1

    1Medical Microbiology and Immunology, University of Toledo College of Medicine, Toledo, OH; 2Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, MA; 3Transplant Immunology Research Program, Houston Methodist Research Institute, Houston, TX.

    BACKGROUND: IL-21 is a cytokine expressed almost exclusively by cells of the adaptive immune system. This makes it an attractive target for reducing chronic allograft…
  • « Previous Page
  • 1
  • …
  • 141
  • 142
  • 143
  • 144
  • 145
  • …
  • 170
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences